These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37153573)

  • 21. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
    Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
    FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental Colitis.
    Al-Shamma H; Lehmann-Bruinsma K; Carroll C; Solomon M; Komori HK; Peyrin-Biroulet L; Adams J
    J Pharmacol Exp Ther; 2019 Jun; 369(3):311-317. PubMed ID: 30872391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice.
    Kobori M; Ni Y; Takahashi Y; Watanabe N; Sugiura M; Ogawa K; Nagashimada M; Kaneko S; Naito S; Ota T
    PLoS One; 2014; 9(5):e98294. PubMed ID: 24858832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of sphingosine-1-phosphate in inflammatory bowel disease.
    Peyrin-Biroulet L; Christopher R; Behan D; Lassen C
    Autoimmun Rev; 2017 May; 16(5):495-503. PubMed ID: 28279838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
    Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ.
    Zhong X; Liu H
    J Gastroenterol Hepatol; 2018 Feb; 33(2):524-532. PubMed ID: 28670854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage RAGE activation is proinflammatory in NASH.
    Parthasarathy G; Mauer AS; Golla N; Daniel PV; Kim LH; Sidhu GS; Marek GW; Loeuillard E; Krishnan A; Lee HSK; Pavelko KD; Charlton M; Hirsova P; Ilyas SI; Malhi H
    JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38175729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.
    Tzeng TF; Tzeng YC; Cheng YJ; Liou SS; Liu IM
    Nutrients; 2015 Oct; 7(10):8670-84. PubMed ID: 26506376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity.
    Wu H; Lou T; Pan M; Wei Z; Yang X; Liu L; Feng M; Shi L; Qu B; Cong S; Chen K; Yang H; Liu J; Li Y; Jia Z; Xiao H
    J Ethnopharmacol; 2024 May; 326():117841. PubMed ID: 38310988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis.
    Zhou J; Tripathi M; Ho JP; Widjaja AA; Shekeran SG; Camat MD; James A; Wu Y; Ching J; Kovalik JP; Lim KH; Cook SA; Bay BH; Singh BK; Yen PM
    Thyroid; 2022 Jun; 32(6):725-738. PubMed ID: 35317606
    [No Abstract]   [Full Text] [Related]  

  • 32. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8
    Muñoz-Durango N; Arrese M; Hernández A; Jara E; Kalergis AM; Cabrera D
    Front Immunol; 2020; 11():563434. PubMed ID: 33391254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes.
    Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH
    J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine 1-Phosphate Receptor 4 Promotes Nonalcoholic Steatohepatitis by Activating NLRP3 Inflammasome.
    Hong CH; Ko MS; Kim JH; Cho H; Lee CH; Yoon JE; Yun JY; Baek IJ; Jang JE; Lee SE; Cho YK; Baek JY; Oh SJ; Lee BY; Lim JS; Lee J; Hartig SM; Conde de la Rosa L; Garcia-Ruiz C; Lee KU; Fernández-Checa JC; Choi JW; Kim S; Koh EH
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):925-947. PubMed ID: 34890841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver.
    Iacobini C; Menini S; Ricci C; Blasetti Fantauzzi C; Scipioni A; Salvi L; Cordone S; Delucchi F; Serino M; Federici M; Pricci F; Pugliese G
    J Hepatol; 2011 May; 54(5):975-83. PubMed ID: 21145823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deconstructing the Pharmacological Contribution of Sphingosine-1 Phosphate Receptors to Mouse Models of Multiple Sclerosis Using the Species Selectivity of Ozanimod, a Dual Modulator of Human Sphingosine 1-Phosphate Receptor Subtypes 1 and 5.
    Selkirk JV; Dines KC; Yan YG; Ching N; Dalvie D; Biswas S; Bortolato A; Schkeryantz JM; Lopez C; Ruiz I; Hargreaves R
    J Pharmacol Exp Ther; 2021 Dec; 379(3):386-399. PubMed ID: 34535564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
    Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis.
    González-Rodríguez Á; Valdecantos MP; Rada P; Addante A; Barahona I; Rey E; Pardo V; Ruiz L; Laiglesia LM; Moreno-Aliaga MJ; García-Monzón C; Sánchez A; Valverde ÁM
    Mol Metab; 2018 Jan; 7():132-146. PubMed ID: 29126873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
    Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways.
    Zhong X; Liu H
    Biomed Pharmacother; 2018 Feb; 98():111-117. PubMed ID: 29247950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.